PANCREASE MT ( DrugBank: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
299	嚢胞性線維症	2

299. 嚢胞性線維症

臨床試験数 : 1,695 / 薬物数 : 1,527 - (DrugBank : 268) / 標的遺伝子数 : 111 - 標的パスウェイ数 : 174

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00662675 (ClinicalTrials.gov)	August 2008	17/4/2008	A Study of the Efficacy and Tolerability of Pancrelipase Microtablet (MT) Capsules for the Treatment ...	A Randomized Double-blind (Withdrawal) Phase 3 Study to Evaluate the Efficacy and Tolerability of Pa ...	Exocrine Pancreatic Insufficiency;Steatorrhea;Malabsorption Syndromes;Cystic Fibrosis	Drug: Pancrease MT 10.5, or MT 21;Drug: Placebo for Pancrease MT 10.5 or MT 21	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	NULL	Completed	7 Years	60 Years	All	40	Phase 3	United States;Canada
2	EUCTR2015-001219-11-Outside-EU/EEA (EUCTR)		31/03/2015	A study of the efficacy and tolerability of pancrelipase microtablet (MT) capsules for the treatment ...	A randomized double-blind (withdrawal) phase 3 study to evaluate the efficacy and tolerability of pa ...	Cystic fibrosis MedDRA version: 17.1;Level: LLT;Classification code 10011765;Term: Cystic fibrosis p ...	Trade Name: PANCREASE MT Product Name: PANCREASE MT INN or Proposed INN: pancrelipase Other descriptive ...	Johnson & Johnson Pharmaceutical Research and Development, L.L.C.	NULL	NA			Female: yes Male: yes	40	Phase 3	United States;Canada

First Previous1Next Last